title: Concentration of ceftiofur metabolites in the plasma and lungs of horses following intramuscular treatment.
abstract: Ceftiofur sodium, a broad spectrum cephalosporin antibiotic approved for veterinary use, is metabolized to desfuroylceftiofur which is conjugated to micro as well as macromolecules. Twelve horses, weighting 442-618 kg, were injected intramuscularly with a single dose of 2.2 mg ceftiofur/kg (1.0 mg/lb) body weight. Blood was collected at various intervals over 24 h after treatment. Three groups of four horses each were euthanized and lungs were collected at 1, 12, and 24 h after treatment. The concentration of desfuroylceftiofur and desfuroylceftiofur conjugates in the plasma and lungs was determined by converting them to desfuroylceftiofur acetamide (DCA) and measured DCA by high performance liquid chromatography with UV detection. The average maximum concentration (Cmax) of desfuroylceftiofur and related metabolites in plasma expressed as ceftiofur equivalents was 4.46 +/- 0.93 micrograms/ml occurred at 1.25 +/- 0.46 h after treatment. These concentrations declined to 0.99 +/- 0.16, 0.47 +/- 0.15 and 0.17 +/- 0.02 microgram/ml at 8, 12, and 24 h, respectively. The mean residence time of ceftiofur metabolites was 6.10 +/- 1.27 h. Concentrations of desfuroylceftiofur and desfuroylceftiofur conjugates in the lungs of horses expressed as ceftiofur equivalents were 1.40 +/- 0.36, 0.27 +/- 0.07, and 0.15 +/- 0.08 micrograms/ml at 1, 12, and 24 h, respectively. These concentrations of the drug at 12 and 24 h in lung homogenate were similar but slightly lower than plasma concentrations in the same horses, and the plasma pharmacokinetic values including half-life were similar to those observed at the approved dose of 1.1-2.2 mg ceftiofur/kg body weight administered intramuscularly once daily for 3-5 days in cattle.
authors.affiliation: Upjohn Company, Kalamazoo, MI 49001.
authors.forename: P S
authors.initials: PS
authors.lastname: Jaglan
authors.forename: R D
authors.initials: RD
authors.lastname: Roof
authors.forename: F S
authors.initials: FS
authors.lastname: Yein
authors.forename: T S
authors.initials: TS
authors.lastname: Arnold
authors.forename: S A
authors.initials: SA
authors.lastname: Brown
authors.forename: T J
authors.initials: TJ
authors.lastname: Gilbertson
mesh_terms: D000818:Animals; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D005260:Female; D006207:Half-Life; D006736:Horses / Q000097:blood*; D007273:Injections, Intramuscular / Q000662:veterinary; D008168:Lung / Q000378:metabolism*; D008297:Male; D014018:Tissue Distribution
chemical_list: D002511:Cephalosporins; C063324:desfuroylceftiofur; C053503:ceftiofur